Strategies & Technologies Driving Drug Discovery to Market
Endo Licenses Novel Pain Therapy from Grunenthal
February 27, 2009 3:53 am | News | CommentsEndo Pharmaceuticals announced that it has licensed from Grunenthal the exclusive rights to develop and market the investigational drug axomadol in the United States and Canada.
Immune Molecule Found that Attacks Wide Range of Flu Viruses
February 27, 2009 3:47 am | News | CommentsThe discovery of the molecule, an antibody known as CR6261, is good news for researchers who hope to design a flu vaccine that would give humans lifelong protection against a majority of influenza viruses.
Obama Calls for Generic Biotech Drugs
February 27, 2009 3:26 am | by Ricardo Alonso-Zaldivar, Associated Press Writer | News | CommentsPresident Barack Obama's budget aims to foster generic competition for costly biotech drugs used to treat cancer and other intractable ailments.
Abbott Completes Acquisition of Advanced Medical Optics
February 27, 2009 3:18 am | News | CommentsAbbott announced that it has completed its acquisition of Advanced Medical Optics.
FDA Slaps Warning On Heartburn Drug Tied To Spasms
February 27, 2009 3:11 am | by Associated Press | News | CommentsFederal health officials are adding their sternest warning to a heartburn drug that has been linked to muscle spasms.
FDA Approves Genzyme’s Synvisc-One
February 26, 2009 8:07 am | News | CommentsGenzyme Corporation announced that the US Food and Drug Administration (FDA) has granted marketing approval for Synvisc-One.
ChanTest Acquires Applied Cell Sciences
February 26, 2009 7:46 am | News | CommentsChanTest announced that it has acquired Rockville, Maryland-based Applied Cell Sciences.
Sequencing Study Reveals New Insights in Drug Resistance
February 26, 2009 7:30 am | News | CommentsNew data from two studies demonstrate that ultra-deep sequencing with the Genome Sequencer FLX System from 454 Life Sciences, in combination with traditional methods, may provide a deeper understanding of baseline viral resistance and tropism.
Proepithelin Encourages Cell Growth in Prostate Cancer
February 26, 2009 6:39 am | News | CommentsResearchers have identified a protein that appears to play a significant role in the growth and migration of prostate cancer cells, especially androgen-independent prostate cancer cells.
Lawyer for Nigeria: Pfizer Settlement Close
February 26, 2009 6:01 am | by Edward Harris, Associated Press Writer | News | CommentsA lawyer representing Nigeria in multi-billion dollar lawsuits against Pfizer said that a settlement is close in the cases stemming from the pharmaceutical giant's 1996 drug trial.
Battelle Ventures Spins Out Life Science Company from MIT
February 26, 2009 5:00 am | News | CommentsBattelle Ventures, LP, has spun out Hepregen Corporation from the Massachusetts Institute of Technology.
Former FDA Commissioner Joins Greenleaf Health
February 26, 2009 4:43 am | News | CommentsGreenleaf Health LLC announced that Andrew C. von Eschenbach, MD, who recently stepped down as Commissioner of the Food and Drug Administration (FDA), has joined the firm as Senior Advisor.
Use of Potassium Iodide Encouraged In Prenatal Vitamins
February 26, 2009 4:17 am | News | CommentsResearchers from Boston University School of Medicine (BUSM) are encouraging prenatal vitamin manufacturers to use only potassium iodide and not other sources of iodine in their products.
Millipore Announces Technology Acquisition
February 26, 2009 3:46 am | News | CommentsMillipore Corporation announced that it has purchased the assets associated with Epitome Biosystems’ EpiTag technology.
Biomarker Predicts Disease Recurrence in Colorectal Cancer
February 26, 2009 3:29 am | News | CommentsFindings by researchers at Thomas Jefferson University show that the presence of a biomarker in regional lymph nodes is an independent predictor of disease recurrence in patients with colorectal cancer.
